Clinical Trials Browser

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT01045460 2021-04-09

aMILs

Phase 2 Completed

36 enrolled 13 charts

Plasma cell

Multiple Myeloma

NCT01329900 2020-07-08

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

Phase 2 Completed

50 enrolled 7 charts

Lymphoid

Lymphoma

NCT00651937 2020-01-14

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Phase 2 Completed

80 enrolled 7 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT01174082 2018-06-01

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Phase 2 Terminated

2 enrolled 7 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00984165 2018-05-02

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2 Terminated

18 enrolled 13 charts

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT01547806 2018-03-07

Collection of Transplant Stem Cells for Plasma Cell Myeloma

Phase 2 Completed

49 enrolled 17 charts

Plasma cell

Multiple Myeloma

NCT02433483 2017-11-01

Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

Phase 2 Terminated

4 enrolled 11 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02098109 2017-07-18

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Phase 2 Completed

100 enrolled 18 charts

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00499343 2013-08-02

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

Phase 2 Completed

84 enrolled 5 charts

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

NCT00001832 2012-12-21

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Phase 2 Completed

170 enrolled 23 charts

BreastDermatologic

Breast Neoplasms, Melanoma, Neoplasm Metastasis

NCT00499889 2012-04-23

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Phase 2 Terminated

42 enrolled 8 charts

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

aMILs

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Collection of Transplant Stem Cells for Plasma Cell Myeloma

Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients